La Jolla Pharmaceutical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 15, 2022 at 08:02 am EDT
La Jolla Pharmaceutical Company reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was USD 10.54 million compared to USD 16.06 million a year ago. Net income was USD 2.46 million compared to USD 3.73 million a year ago. Basic earnings per share from continuing operations was USD 0.1 compared to USD 0.14 a year ago. Diluted earnings per share from continuing operations was USD 0.08 compared to USD 0.11 a year ago.
For the six months, revenue was USD 20.97 million compared to USD 50.2 million a year ago. Net income was USD 2.46 million compared to USD 18.15 million a year ago. Basic earnings per share from continuing operations was USD 0.1 compared to USD 0.66 a year ago. Diluted earnings per share from continuing operations was USD 0.08 compared to USD 0.53 a year ago.